Earnings Feed
Start Free
Home/Filings/3/0000899243-23-019097
3//SEC Filing

Versant Venture Capital VII, L.P. 3

Accession 0000899243-23-019097

CIK 0001825367other
View on SEC.govCompany Profile

Filed

Sep 13, 8:00 PM ET

Accepted

Sep 14, 9:17 PM ET

Size

18.6 KB

Accession

0000899243-23-019097

Insider Transaction Report

Form 3
Period: 2023-09-14
RayzeBio, Inc.RYZB
Versant Vantage I, L.P.
10% Owner
Holdings

  • Series A Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (3,786,957 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (778,058 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (345,803 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (247,343 underlying)
Versant Ventures VII GP-GP, LLC
10% Owner
Holdings

  • Series A Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (3,786,957 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (345,803 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (247,343 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (778,058 underlying)
Versant Ventures VII GP, L.P.
10% Owner
Holdings

  • Series B Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (778,058 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (345,803 underlying)

  • Series A Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (3,786,957 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (247,343 underlying)
Versant Venture Capital VII, L.P.
10% Owner
Holdings

  • Series B Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (778,058 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (345,803 underlying)

  • Series A Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (3,786,957 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (247,343 underlying)
Versant Vantage I GP-GP, LLC
10% Owner
Holdings

  • Series B Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (778,058 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (345,803 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (247,343 underlying)

  • Series A Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (3,786,957 underlying)
Versant Vantage I GP, L.P.
10% Owner
Holdings

  • Series B Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (345,803 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (778,058 underlying)

  • Series A Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (3,786,957 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See Footnote)
    → Common Stock (247,343 underlying)
Footnotes (4)
  • [F1]Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (the "Preferred Stock") is convertible into shares of Common Stock of the Issuer on a one-for-one basis without payment of additional consideration. Upon the closing of the Issuer's initial public offering (the "IPO"), the Preferred Stock will convert into the number of shares of Common Stock of the Issuer shown in column 3. The Preferred Stock has no expiration date.
  • [F2]Each share Series C Convertible Preferred Stock (the "Series C Preferred Stock") is convertible into shares of Common Stock of the Issuer on a one-for-1.14443753806379 basis without payment of additional consideration. Upon the closing of the IPO, the Series C Preferred Stock will convert into the number of shares of Common Stock of the Issuer shown in column 3. The Series C Preferred Stock has no expiration date.
  • [F3]These shares are held of record by Versant Venture Capital VII, L.P. ("Versant VII"). Versant Ventures VII GP-GP, LLC ("Versant VII GP LLC") is the general partner of Versant Ventures VII GP, L.P. ("Versant VII GP LP"), which is the general partner of Versant VII, and may be deemed to have shared voting, investment and dispositive power with respect to such shares. Each of Versant VII GP LLC and Versant VII GP LP disclaims beneficial ownership of the shares held by Versant VII, except to the extent of their respective pecuniary interests therein, if any.
  • [F4]These shares are held of record by Versant Vantage I, L.P. ("Vantage I"). Versant Vantage I GP-GP, LLC ("Vantage I GP LLC") is the general partner of Versant Vantage I GP, L.P. ("Vantage I GP LP"), which is the general partner of Vantage I, and may be deemed to have shared voting, investment and dispositive power with respect to such shares. Each of Vantage I GP LLC and Vantage I GP LP disclaims beneficial ownership of the shares held by Vantage I, except to the extent of their respective pecuniary interests therein, if any.

Documents

1 file

Issuer

RayzeBio, Inc.

CIK 0001825367

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001750266

Filing Metadata

Form type
3
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 9:17 PM ET
Size
18.6 KB
View on SEC.gov